With approval, Saphnelo would be the first available treatment for systematic lupus erythematosus in Europe in over ten years.
News
Cancer researchers across the UK partner in new trial to find drugs for rare cancers
The DETERMINE trial aims to discover whether existing ‘licensed’ drugs could also benefit patients with rare cancer types that the drug is not currently licensed for.
Positive CHMP opinion for finerenone as new treatment for chronic kidney disease and type 2 diabetes
It is estimated that chronic kidney disease affects more than 160 million people with type 2 diabetes worldwide.
Xeris Biopharma’s glucagon injection becomes available in UK
Tetris Pharma’s Ogluo is the first ready-to-use, pre-mixed and pre-measured glucagon injection.
NICE recommends monotherapy for adjuvant treatment of stage 3 melanoma
The approval follows a successful period of monitoring and patient access through the Cancer Drugs Fund.
Kineret receives positive CHMP opinion for treatment of COVID-19 pneumonia
The European Medicines Agency has recommended approval for use of Kineret in COVID-19 to the European Commission, which will issue a final decision.
NICE recommend venetoclax and azacytidine for patients with aggressive blood cancer
Venetoclax is an oral once-daily treatment, which blocks the action of the B-cell lymphoma-2 protein, the presence of which helps cancer cells survive.
Study finds Omicron multiplies 70 times faster than Delta, UK COVID-19 cases exceed 75,000
A warning has been issued to UK MPs from the head of NHS England that hospitalisations could exceed numbers recorded in January 2021.
Needle free COVID-19 vaccine trialled in UK
The DIOSvax technology produced by the University of Southampton aims to predict how the virus could mutate.
Vaccines still provide ‘significant protection’ against severe COVID-19
Omicron has been the latest variant to test the effectiveness of COVID-19 vaccines.
UK COVID-19 vaccine pledge faces logistical challenges
The public have been assured more sites, mobile units and pop-ups would be set up across the country to fulfill the vaccination pledge ahead of the original deadline of 31 January 2022.
SMC approves first immunotherapy combination for advanced bowel cancer patients with rare mutation
Nivolumab plus ipilmumab has been accepted as a treatment option for adult patients by NHS Scotland for patients who have previously failed fluoropyrimidine-based chemotherapy.
European Commission approves Pfizer’s atopic dermatitis treatment
The approval from the European Commission (EC) is based on the results of five clinical studies, involving over 2,800 patients.
Five-drug combination for ultra-high-risk bone marrow cancer identified
A team at The Institute of Cancer Research (ICR), London and the Clinical Trials Research Unit (CTRU) at the University of Leeds adopted a new high-speed trial methodology.
NHS waiting times reach record high of nearly six million
In October 2021, over 356,000 people in England had been waiting for over six weeks for a key diagnostic test
